insights_auto
Why is LONN up 4.73%?
Dive Deeperchevron_right
LONN:VIE
Lonza Group AG
€654.80
arrow_upward
+4.73%(+29.60) 1D
Oct 15, 5:36:00 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LONN...
Open
€645.40
High
€654.80
Low
€644.80
Mkt. cap
42.40B
Avg. vol.
0.00
Volume
0.00
52-wk high
€654.80
52-wk low
€499.60
No. of employees
20K
Open
€645.40
High
€654.80
Low
€644.80
Mkt. cap
42.40B
Avg. vol.
0.00
Volume
0.00
52-wk high
€654.80
52-wk low
€499.60
No. of employees
20K
News stories
From web sources and news partners
Nutraceutical Business Review
·
5 hours ago
Lonza Capsugel to showcase plant-based Organicaps and advanced capsule technologies at SupplySide Global
ad-hoc-news.de
·
11 hours ago
Lonza lifts mid-term margin goal as Lonza Group stock trades at EUR 645.30
Profile
Lonza Group AG is a Swiss multinational manufacturing company for the pharmaceutical, biotechnology and nutrition sectors, headquartered in Basel, with major facilities in Europe, North America and South Asia. Lonza was established under that name in the late 19th-century in Switzerland. The company provides product development services to the pharmaceutical and biologic industries, including custom manufacturing of biopharmaceuticals and detection systems and services for the bioscience sector. Wikipedia
About Lonza Group AG
CEOWolfgang Wienand
Employees20.1K
Founded1897
HeadquartersBasel, Basel City, Switzerland
SectorHealth care
Websitelonza.com